Role of Teduglutide in Managing Chronic Intestinal Failure

Session Date
Session Date: 
November 1, 2022
Didactic
Didactic: 
Palle Jeppesen, MD, PhD, Copenhagen, Denmark
At the end of this activity, participants will be able to
At the end of this activity, participants will be able to: 
  1. Describe the physiology of GLP-2 in SBS-IF
  2. Describe results of the STEPS Trial for teduglutide use
  3. Discuss differential responses to GLP2 based on intestinal anatomy